Cancer BiologybioRxivPreprint
METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression
Kanchan Kumari, Iván Pérez-Núñez, Aleix Noguera‐Castells…·Francesca Aguiló
This study identifies METTL3-mediated m6A modification of DNMT1 as a driver of ovarian cancer progression by enhancing DNMT1 translation and suppressing tumor suppressors.
DOI 10.1101/2025.09.10.675425